Literature DB >> 19773721

Acute kidney injury and multiple organ dysfunction syndrome.

S Faubel1.   

Abstract

Acute kidney injury occurs in approximately 30% patients admitted to the intensive care unit and is commonly associated with multiple organ dysfunction syndrome. A decade ago, acute kidney injury was thought to be a benign entity that could be managed easily with supportive care and dialysis. It is now known that acute kidney injury has a tremendous negative impact on patient morbidity and mortality. Although epidemiologic data clearly demonstrate that acute kidney injury is independently associated with increased mortality, the mechanisms by which acute kidney injury causes death remain unclear. One explanation for the increased mortality is that acute kidney injury causes deleterious systemic effects including injury to other organs. In this review, clinical and experimental data demonstrating the role of acute kidney injury in affecting inflammation and distant organ dysfunction will be discussed with the view that acute kidney injury is a critical factor in the development and maintenance of multiple organ dysfunction syndrome. Current recommendations regarding management of AKI in light of these data and recent clinical trials will also be discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19773721

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  19 in total

1.  Multiple-Drug Resistance in Burn Patients: A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay.

Authors:  Ilse van Langeveld; Robin C Gagnon; Peggie F Conrad; Richard L Gamelli; Brendan Martin; Mashkoor A Choudhry; Michael J Mosier
Journal:  J Burn Care Res       Date:  2017 Mar/Apr       Impact factor: 1.845

Review 2.  Mechanisms and mediators of lung injury after acute kidney injury.

Authors:  Sarah Faubel; Charles L Edelstein
Journal:  Nat Rev Nephrol       Date:  2015-10-06       Impact factor: 28.314

3.  Ultrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI.

Authors:  Joseph C Gigliotti; Liping Huang; Amandeep Bajwa; Hong Ye; Eric H Mace; John A Hossack; Kambiz Kalantari; Tsuyoshi Inoue; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

4.  Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy.

Authors:  Sang Won Park; Sean W C Chen; Mihwa Kim; Kevin M Brown; Jay K Kolls; Vivette D D'Agati; H Thomas Lee
Journal:  Lab Invest       Date:  2010-08-09       Impact factor: 5.662

5.  Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression after acute ischemia.

Authors:  Purvi Mehrotra; Jason A Collett; Susan J Gunst; David P Basile
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-14       Impact factor: 3.619

6.  Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.

Authors:  Catherine Ingels; Holger J Møller; Troels K Hansen; Pieter J Wouters; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  J Clin Immunol       Date:  2012-11-13       Impact factor: 8.317

7.  IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI.

Authors:  Joo Yun Kim; Mihwa Kim; Ahrom Ham; Kevin M Brown; Robert W Greene; Vivette D D'Agati; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 10.121

8.  Paneth cell-mediated multiorgan dysfunction after acute kidney injury.

Authors:  Sang Won Park; Mihwa Kim; Joo Yun Kim; Ahrom Ham; Kevin M Brown; Yuko Mori-Akiyama; André J Ouellette; Vivette D D'Agati; H Thomas Lee
Journal:  J Immunol       Date:  2012-10-29       Impact factor: 5.422

9.  Continuous blood purification ameliorates clinical signs and corrects the plasma phospholipid levels of patients with multiple organ dysfunction syndromes.

Authors:  Wei Wen; Kun Wang; Zhi-Ming Jiang; Zhong-Hui Zhang; Lei Zhou
Journal:  J Clin Lab Anal       Date:  2018-02-18       Impact factor: 2.352

10.  Critical role of interleukin-11 in isoflurane-mediated protection against ischemic acute kidney injury in mice.

Authors:  Ahrom Ham; Mihwa Kim; Joo Yun Kim; Kevin M Brown; James Yeh; Vivette D D'Agati; H Thomas Lee
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.